ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CERS vs MRK // GROSS PROFIT MARGIN

Cerus Corporation (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: CERS 1 — MRK 9
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CERS VS. MRK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CERS MRK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 74.80% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -15.50% 20.70% -36.20 MRK /roic <GO>
EV/EBITDA & P/E Valuation — 15.3x — TIE /valuation <GO>
Free Cash Flow Yield 0.23% 3.42% -3.19 MRK /fcf-yield <GO>
Operating Margin -3.70% 34.30% -38.00 MRK /operating-margins <GO>
Net Profit Margin -6.70% 28.10% -34.80 MRK /net-margins <GO>
Revenue Growth (YoY) 16.10% 1.30% +14.80 CERS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.26% -2.26 MRK /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 5.19 -4.99 MRK /balance-sheet <GO>
Piotroski F-Score Quality 6/9 7/9 -1.00 MRK /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.0 51.7 -8.66 MRK /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.92 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 18.4x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $491.7M $361.02B -$360.53B MRK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CERS REV MRK REV CERS GROSS % MRK GROSS % CERS FCF MRK FCF
FY 2025 $233.8M $65.01B — 74.8% $1.1M $12.36B
FY 2024 $201.3M $64.17B — 76.3% $8.5M $18.10B
FY 2023 $186.8M $60.12B — — -$43.2M $10.30B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CERS // BETA —
MRK // BETA 0.92